Jeffrey A. Morgan
Researcher Next ID · RN-042443
Researcher · Engineering
Ramat Gan, Israel
- Works count
- 363
- Citation count
- 15,261
- H-index
- 57
- i10-index
- 150
Research interests
Publications
Survival on the Heart Transplant Waiting List
JAMA Cardiology · 2020 · 10.1001/jamacardio.2020.2795
Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study
Cancer · 2017 · 10.1002/cncr.30738
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
Annals of Oncology · 2016 · 10.1093/annonc/mdw228
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy
BMC Cancer · 2014 · 10.1186/1471-2407-14-813
Impact of continuous-flow left ventricular assist device support on right ventricular function
The Journal of Heart and Lung Transplantation · 2013 · 10.1016/j.healun.2012.12.018
The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary
The Journal of Heart and Lung Transplantation · 2013 · 10.1016/j.healun.2012.09.013
Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial
Journal of Clinical Oncology · 2012 · 10.1200/jco.2011.39.9394
Gastrointestinal bleeding with the HeartMate II left ventricular assist device
The Journal of Heart and Lung Transplantation · 2012 · 10.1016/j.healun.2012.02.015
A phase I–II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors
Annals of Oncology · 2010 · 10.1093/annonc/mdq076
Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors
Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.25.2981
Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors
Clinical Cancer Research · 2010 · 10.1158/1078-0432.ccr-10-2621
Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
Clinical Cancer Research · 2009 · 10.1158/1078-0432.ccr-09-0224
Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure
Clinical Cancer Research · 2009 · 10.1158/1078-0432.ccr-09-0482
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure
European Journal of Cancer · 2009 · https://doi.org/10.1016/j.ejca.2009.02.011
Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas
Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.20.9890
A Preeclampsia-like Syndrome Characterized by Reversible Hypertension and Proteinuria Induced by the Multitargeted Kinase Inhibitors Sunitinib and Sorafenib
JNCI Journal of the National Cancer Institute · 2008 · 10.1093/jnci/djm311
Leiomyosarcoma of the Inferior Vena Cava: Survival After Aggressive Management
Annals of Surgical Oncology · 2007 · 10.1245/s10434-007-9552-z
Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors
Clinical Cancer Research · 2007 · 10.1158/1078-0432.ccr-06-0858
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
The Lancet · 2007 · 10.1016/s0140-6736(07)61865-0
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
The Lancet · 2006 · https://doi.org/10.1016/s0140-6736(06)69446-4
Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors
Annals of Internal Medicine · 2006 · 10.7326/0003-4819-145-9-200611070-00008
Surgical Management of Advanced Gastrointestinal Stromal Tumors After Treatment With Targeted Systemic Therapy Using Kinase Inhibitors
Journal of Clinical Oncology · 2006 · 10.1200/jco.2005.05.3439
Does Robotic Technology Make Minimally Invasive Cardiac Surgery Too Expensive? A Hospital Cost Analysis of Robotic and Conventional Techniques
Journal of Cardiac Surgery · 2005 · 10.1111/j.1540-8191.2005.200385.x
Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality
The Annals of Thoracic Surgery · 2004 · 10.1016/j.athoracsur.2003.09.048
Totally Endoscopic Atrial Septal Defect Repair With Robotic Assistance
Circulation · 2003 · 10.1161/01.cir.0000089043.82199.2f
Current projects
No projects listed.